
Current Price | $22.25 | Mkt Cap | $791.6M |
---|---|---|---|
Open | $22.79 | P/E Ratio | 3.02 |
Prev. Close | $22.25 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.43 - $23.00 | Volume | 237,362 |
52-Wk Range | $16.21 - $37.88 | Avg. Daily Vol. | 379,483 |
Current Price | $22.25 | Mkt Cap | $791.6M |
---|---|---|---|
Open | $22.79 | P/E Ratio | 3.02 |
Prev. Close | $22.25 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.43 - $23.00 | Volume | 237,362 |
52-Wk Range | $16.21 - $37.88 | Avg. Daily Vol. | 379,483 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about ITOS.
Recs
I also love the prospects for this company.
Recs
Iteos Therapeutics, Inc is a small cap company focused on the development of biopharmaceuticals products and services. Iteos presently has two clinical-stage product candidates, Inupadenant (EOS-850) and EOS-448. Inupadenant targets the ATP adenosine pathway, while EOS-448 targets TIGIT (T cell immunoreceptor with immunoglobulin and ITIM domains). Anti-TIGIT is the next wave in oncology treatments and Iteos is one of the leaders. I think it will pay off big.
Find the members with the highest scoring picks in ITOS.
cruisin25 (59.35) Score: +27.35
The Score Leader is the player with the highest score across all their picks in ITOS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
ababrmon | 65.00 | 1/18/2023 |
![]() |
5Y | $19.75 | +12.66% | +1.83% | +10.83 | 0 Comment | |
CMFMLove | 36.11 | 2/9/2021 |
![]() |
5Y | $39.80 | -44.10% | +3.73% | -47.83 | 1 Comment | |
BamaFool72 | < 20 | 2/9/2021 |
![]() |
5Y | $40.12 | -44.54% | +3.64% | -48.18 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.